Three-year follow up data from the TEMPO randomized controlled trial supports evidence of TIF procedure as an effective, long-term treatment option for GERD REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for...
Newly Issued Technology Coverage Statement on Minimally Invasive Surgical Options for GERD REDMOND, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that Health Care...
REDMOND, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the American Gastroenterological Association (AGA) has issued a Technology Coverage Statement on Minimally...
Latest EsophyX® Z Fastener Delivery System Significantly Reduces the Number of Steps in the TIF® (Transoral Incisionless Fundoplication) Procedure REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal...